These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 22328359)

  • 1. Human teratogens update 2011: can we ensure safety during pregnancy?
    Rasmussen SA
    Birth Defects Res A Clin Mol Teratol; 2012 Mar; 94(3):123-8. PubMed ID: 22328359
    [TBL] [Abstract][Full Text] [Related]  

  • 2. We don't know what we don't study: the case for research on medication effects in pregnancy.
    Parisi MA; Spong CY; Zajicek A; Guttmacher AE
    Am J Med Genet C Semin Med Genet; 2011 Aug; 157C(3):247-50. PubMed ID: 21766436
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prenatal exposure to teratogenic medications in the era of Risk Evaluation and Mitigation Strategies.
    Sarayani A; Albogami Y; Thai TN; Smolinski NE; Patel P; Wang Y; Nduaguba S; Rasmussen SA; Winterstein AG
    Am J Obstet Gynecol; 2022 Aug; 227(2):263.e1-263.e38. PubMed ID: 35032444
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Knowledge transfer and translation: examining how teratogen information is disseminated.
    Shahin I; Einarson A
    Birth Defects Res A Clin Mol Teratol; 2011 Nov; 91(11):956-61. PubMed ID: 21948595
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An update on teratogens for pediatric healthcare providers.
    Valladares DA; Rasmussen SA
    Curr Opin Pediatr; 2022 Dec; 34(6):565-571. PubMed ID: 36081369
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dose-Dependent Teratology in Humans: Clinical Implications for Prevention.
    Koren G; Berkovitch M; Ornoy A
    Paediatr Drugs; 2018 Aug; 20(4):331-335. PubMed ID: 29725877
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Postmarketing surveillance for drug safety in pregnancy: the Organization of Teratology Information Services project.
    Felix RJ; Jones KL; Johnson KA; McCloskey CA; Chambers CD;
    Birth Defects Res A Clin Mol Teratol; 2004 Dec; 70(12):944-7. PubMed ID: 15570610
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The estimation of human teratogenic/fetotoxic risk of exposures to drugs on the basis of Hungarian experience: a critical evaluation of clinical and epidemiological models of human teratology.
    Czeizel AE
    Expert Opin Drug Saf; 2009 May; 8(3):283-303. PubMed ID: 19505262
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adverse drug reactions in utero: perspectives on teratogens and strategies for the future.
    Mitchell AA
    Clin Pharmacol Ther; 2011 Jun; 89(6):781-3. PubMed ID: 21593753
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Counselling pregnant women at the crossroads of Europe and Asia: effect of Teratology Information Service in Turkey.
    Kaplan YC; Karadaş B; Küçüksolak G; Ediz B; Demir Ö; Sozmen K; Nordeng H
    Int J Clin Pharm; 2017 Aug; 39(4):783-790. PubMed ID: 28626851
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Principles of human teratology: drug, chemical, and infectious exposure.
    Wilson RD; ;
    J Obstet Gynaecol Can; 2007 Nov; 29(11):911-917. PubMed ID: 17977495
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human teratogens: update 2010.
    Holmes LB
    Birth Defects Res A Clin Mol Teratol; 2011 Jan; 91(1):1-7. PubMed ID: 21254353
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug use during pregnancy and breast-feeding. A classification system for drug information.
    Berglund F; Flodh H; Lundborg P; Prame B; Sannerstedt R
    Acta Obstet Gynecol Scand Suppl; 1984; 126():1-55. PubMed ID: 6393685
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prescribing in pregnancy and during breast feeding: using principles in clinical practice.
    Henderson E; Mackillop L
    Postgrad Med J; 2011 May; 87(1027):349-54. PubMed ID: 21273359
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protocol of a prospective and multicentre China Teratology Birth Cohort (CTBC): association of maternal drug exposure during pregnancy with adverse pregnancy outcomes.
    Zhou Y; Tao J; Wang K; Deng K; Wang Y; Zhao J; Chen C; Wu T; Zhou J; Zhu J; Li X
    BMC Pregnancy Childbirth; 2021 Sep; 21(1):593. PubMed ID: 34470618
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drugs associated with teratogenic mechanisms. Part I: dispensing rates among pregnant women in the Netherlands, 1998-2009.
    van Gelder MM; Bos JH; Roeleveld N; de Jong-van den Berg LT
    Hum Reprod; 2014 Jan; 29(1):161-7. PubMed ID: 24105826
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An update on maternal medication-related embryopathies.
    Gheysen W; Kennedy D
    Prenat Diagn; 2020 Aug; 40(9):1168-1177. PubMed ID: 32524623
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Treatment of depressed pregnant women by selective serotonin reuptake inhibitors: risk for the foetus and the newborn].
    Favrelière S; Nourrisson A; Jaafari N; Pérault Pochat MC
    Encephale; 2010 Jun; 36 Suppl 2():D133-8. PubMed ID: 20513456
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Common teratogenic medication exposures-a population-based study of pregnancies in the United States.
    Wang Y; Smolinski NE; Thai TN; Sarayani A; Ewig C; Rasmussen SA; Winterstein AG
    Am J Obstet Gynecol MFM; 2024 Jan; 6(1):101245. PubMed ID: 38061552
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.